Contributors | |
Preface | |
Physiology | |
StructureûFunction Relationships: the Pathophysiology of Airflow Obstruction | |
The Physiology of Breathlessness | |
The Physiology of Muscle | |
Exercise Limitations and Cardiopulmonary Exercise Testing in COPD | |
Clinical Assessment of Control of Breathing | |
Physiology and Pathobiology of the Lung Circulation | |
Sleep in Patients with COPD | |
The Physiology of Cough | |
The Physiology of Gas Exchange | |
COPD and Allied Conditions | |
The Natural History of COPD | |
Cystic Fibrosis | |
Bronchiectasis and COPD | |
Obliterative Bronchiolitis | |
Asthma | |
COPD: Clinical Presentation and Evaluation | |
Monitoring and Outcomes | |
Host Defences and Inflammation | |
Mucociliary Clearance | |
Mucosal Immunity | |
COPD and Pulmonary Surfactant | |
The Macrophage and its Role in the Pathogenesis of COPD | |
Eosinophils and COPD | |
Airway Epithelial Defence, Repair and Regeneration | |
The Role of the Neutrophil in the Pathogenesis of COPD | |
Lymphocytes | |
Cytokines | |
Leukotrienes in COPD: The Unexploited Potential | |
Cigarette Smoking, Emphysema and Lung Endothelium | |
Mesenchymal Cells of the Lung | |
Pathogenesis | |
Lung Development | |
Animal Models | |
Proteinases and COPD | |
Oxidants | |
Cigarette Smoke-Induced Disease | |
COPD and Air Pollution | |
Viruses in COPD | |
Bacteria | |
Genetic Factors | |
Antitrypsin Deficiency | |
Body Weight and Systemic Effects | |
Lung Connective Tissue | |
Clinical Considerations and Complications | |
Aerosols and Delivery Systems | |
Gastro-oesophageal Reflux | |
Upper Airway Diseases | |
Acute Pulmonary Embolism | |
COPD and Lung Cancer | |
Infection Management and Airflow Obstruction | |
Mechanical Ventilation for Exacerbation of COPD | |
Comorbidity | |
Current and Future Treatment | |
Primary Care | |
Pulmonary Rehabilitation | |
Social Support | |
Long-Term Invasive Mechanical Ventilation | |
Smoking Cessation | |
Oxygen Therapy in COPD | |
Surgical Therapy for COPD | |
Anticholinergics in COPD | |
Agonists | |
Corticosteroids | |
Phosphodiesterase 4 Inhibitors in the Treatment of COPD | |
Antibiotic Therapy in Patients with COPD | |
Antioxidants | |
Mucolytics for COPD | |
End-of-Life and Palliative Care for Patients with COPD | |
Economic Burden of COPD | |
Pharmacoepidemiology of COPD | |
Social and Behavioural Impact of COPD û Research Opportunities | |
Guidelines | |
Pharmacotherapy: Developing Therapies | |
Protease Inhibitors | |
Retinoids | |
Chemokines in COPD | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.